Fenoterol hydrobromide and Etoposide drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Fenoterol hydrobromide (fenoterol hydrobromide) and Etoposide (etoposide). Common drug interactions include staphylococcal sepsis among females and febrile bone marrow aplasia among males.

The phase IV clinical study analyzes what interactions people have when they take Fenoterol hydrobromide and Etoposide. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.

What is Fenoterol hydrobromide?

Fenoterol hydrobromide has active ingredients of fenoterol hydrobromide. eHealthMe is studying from 1,327 Fenoterol hydrobromide users. Check the latest studies of Fenoterol hydrobromide.

What is Etoposide?

Etoposide has active ingredients of etoposide. eHealthMe is studying from 77,815 Etoposide users. Check the latest studies of Etoposide.

On Jul, 05, 2026

35 people who take Fenoterol hydrobromide and Etoposide together, and have interactions are studied.

Fenoterol hydrobromide and Etoposide drug interactions.

What are the common drug interactions of Fenoterol Hydrobromide and Etoposide, by gender? *:

female:

Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
Troponin increased
Hypokalaemia (low potassium)
Anaemia (lack of blood)
Blood lactate dehydrogenase increased
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Abdominal pain upper
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
C-reactive protein increased

male:

Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Melaena (the passage of black, tarry stools)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Anaemia (lack of blood)
Anaemia macrocytic (a macrocytic class of anaemia)
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
Cystitis viral (inflammation of the wall of the bladder by virus)
Dehydration (dryness resulting from the removal of water)
Eosinophilia (eosinophil count in the peripheral blood exceeds)

What are the common drug interactions of Fenoterol Hydrobromide and Etoposide, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
Acute graft versus host disease in skin (acute complication on skin following an allogeneic tissue/blood transplant)
Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
Seizure (abnormal excessive or synchronous neuronal activity in the brain)
Cystitis viral (inflammation of the wall of the bladder by virus)
Human herpesvirus 6 infection

10-19:

n/a

20-29:

n/a

30-39:

Acute interstitial pneumonitis (acute revere lung disease)

40-49:

Hypokalaemia (low potassium)
Blood lactate dehydrogenase increased
Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
Abdominal pain upper
Anaemia (lack of blood)
Aspartate aminotransferase increased
Blood alkaline phosphatase increased
Constipation
Febrile neutropenia (fever with reduced white blood cells)
Hypoalbuminaemia (levels of albumin in blood serum are abnormally low)

50-59:

n/a

60+:

Febrile bone marrow aplasia (bone marrow greatly decreases or stops production of blood cells)
Melaena (the passage of black, tarry stools)
Nausea (feeling of having an urge to vomit)
Pancytopenia (medical condition in which there is a reduction in the number of red and white blood cells, as well as platelets)
Anaemia macrocytic (a macrocytic class of anaemia)
Asthenia (weakness)
Atrial fibrillation (fibrillation of the muscles of the atria of the heart)
C-reactive protein increased
Dehydration (dryness resulting from the removal of water)
Eosinophilia (eosinophil count in the peripheral blood exceeds)

What are the existing conditions these people have? *

Small Cell Lung Cancer Extensive Stage (small cell lung cancer that has spread (metastasized) to other regions of the body such as another lobe of the lung or the brain): 17 people, 48.57%
Chronic Obstructive Pulmonary Disease (a progressive disease that makes it hard to breathe): 9 people, 25.71%
Bronchial Carcinoma (lung cancer): 6 people, 17.14%
Myocardial Ischaemia (the blood flow through one or more of the blood vessels that lead to heart (coronary arteries) is decreased): 6 people, 17.14%
High Blood Cholesterol: 4 people, 11.43%
Lung Cancer - Non-Small Cell (lung cancer): 4 people, 11.43%
Hypothyroidism (abnormally low activity of the thyroid gland, resulting in retardation of growth and mental development): 4 people, 11.43%
High Blood Pressure: 3 people, 8.57%
Testicular Cancer (cancer that develops in the testicles): 3 people, 8.57%
Hypokalemia (low potassium): 3 people, 8.57%

* Approximation only. Some reports may have incomplete information.

Do you take Fenoterol hydrobromide and Etoposide?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously